Arkansas Defective Breast Mesh & Reconstruction Device Injury Attorneys: Attorney911 Brings 27+ Years of Federal-Court Trial Experience to Arkansas Patients Facing BIA-ALCL, BIA-SCC, and Implant Failures in Little Rock, Fayetteville and Beyond — We Handle Allergan BIOCELL Textured Implants Recalled July 2019, Now MDL 2921 Before Judge Brian R. Martinotti With Bellwether October 19, 2026, Mentor MemoryGel, Sientra OPUS, AlloDerm and Strattice ADM, GalaFLEX P4HB Scaffolds and Polypropylene Mesh, Ralph Manginello and Lupe Peña (Former Insurance Defense Internal Counsel With Fluent Spanish) Litigate Federal Preemption Under Riegel, Lohr and Buckman and 21 CFR Parts 803, 807, 814, Addressing Arkansas’s 3-Year Product Liability Statute of Limitations and Discovery Rule While Extracting CD30+/ALK- Pathology Slides and Operative Reports, $50M+ Recovered for Families and Active $10M Bermudez v. Pi Kappa Phi Litigation — Free 24/7 Consultation, No Fee Unless We Recover Compensation for You, Hablamos Español, 1-888-ATTY-911
Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Arkansas: The Complete Guide for Women, Families, and Survivors For women across Arkansas—from the medical hubs of Little Rock and North Arkansas to the communities of the Delta and the Ozarks—the journey of breast reconstruction or aesthetic enhancement is one built on hope. Whether you are a survivor who walked through the doors of the UAMS Winthrop P. Rockefeller Cancer Institute for a life-saving mastectomy or a mother in Fayetteville seeking to restore your confidence after pregnancy, you trusted that the medical devices placed inside your body were safe. You trusted that the surgical mesh, acellular dermal matrix (ADM), or bioabsorbable scaffold reinforcement used to create your "internal bra" had been rigorously tested and approved for use in human breast tissue. The truth we have uncovered is far more troubling. At The Manginello Law Firm, PLLC, operating as Attorney911, we have dedicated ourselves to exposing a regulatory failure that has left thousands of women in Arkansas and across the United States at risk. Many of the most common products used in breast procedures today—including GalaFLEX, Phasix, AlloDerm, and Strattice—entered the market through a regulatory shortcut known as the 510(k) clearance pathway. This mechanism allowed manufacturers to sell these devices by claiming they were "substantially equivalent" to older products, some as unrelated as surgical sutures, without ever proving they were safe for the specific, delicate environment of the breast. If you are experiencing persistent pain, late-onset swelling, redness, or…